These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27991935)

  • 1. Is there a link between TNF gene expression and cognitive deficits in depression?
    Bobińska K; Gałecka E; Szemraj J; Gałecki P; Talarowska M
    Acta Biochim Pol; 2017; 64(1):65-73. PubMed ID: 27991935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MMP genes in recurrent depressive disorders and cognitive functions.
    Bobińska K; Szemraj J; Gałecki P; Talarowska M
    Acta Neuropsychiatr; 2016 Aug; 28(4):221-31. PubMed ID: 26856768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
    Xu F; Zhou G; Han S; Yuan W; Chen S; Fu Z; Li D; Zhang H; Li D; Pang D
    PLoS One; 2014; 9(7):e101138. PubMed ID: 25010932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental intestinal endometriosis is characterized by increased levels of soluble TNFRSF1B and downregulation of Tnfrsf1a and Tnfrsf1b gene expression.
    Rojas-Cartagena C; Appleyard CB; Santiago OI; Flores I
    Biol Reprod; 2005 Dec; 73(6):1211-8. PubMed ID: 16093357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression.
    Talarowska M; Szemraj J; Kowalczyk M; Gałecki P
    Med Sci Monit; 2016 Jan; 22():152-60. PubMed ID: 26768155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.
    Hoseth EZ; Ueland T; Dieset I; Birnbaum R; Shin JH; Kleinman JE; Hyde TM; Mørch RH; Hope S; Lekva T; Abraityte AJ; Michelsen AE; Melle I; Westlye LT; Ueland T; Djurovic S; Aukrust P; Weinberger DR; Andreassen OA
    Schizophr Bull; 2017 Jul; 43(4):881-890. PubMed ID: 28049760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.
    Gałecki P; Talarowska M; Bobińska K; Kowalczyk E; Gałecka E; Lewiński A
    Neuro Endocrinol Lett; 2013; 34(8):780-6. PubMed ID: 24522026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Szemraj J; Zajączkowska M; Gałecki P
    Med Sci Monit; 2014 Jun; 20():905-12. PubMed ID: 24881886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functions in first-episode depression and recurrent depressive disorder.
    Talarowska M; Zajączkowska M; Gałecki P
    Psychiatr Danub; 2015 Mar; 27(1):38-43. PubMed ID: 25751430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
    Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
    Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase gene expression and cognitive functions in depression.
    Talarowska M; Szemraj J; Gałecki P
    Adv Med Sci; 2015 Mar; 60(1):1-5. PubMed ID: 25038328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder.
    Talarowska M; Orzechowska A; Szemraj J; Su KP; Maes M; Gałecki P
    Neuropsychobiology; 2014; 70(1):23-8. PubMed ID: 25171019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Orzechowska A; Chamielec M; Bartosz G; Kowalczyk E
    Neurosci Lett; 2012 Feb; 510(2):127-31. PubMed ID: 22273980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF receptors 1 and 2 exert distinct region-specific effects on striatal and hippocampal grey matter volumes (VBM) in healthy adults.
    Stacey D; Redlich R; Büschel A; Opel N; Grotegerd D; Zaremba D; Dohm K; Bürger C; Meinert SL; Förster K; Repple J; Kaufmann C; Kugel H; Heindel W; Arolt V; Dannlowski U; Baune BT
    Genes Brain Behav; 2017 Mar; 16(3):352-360. PubMed ID: 27528091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population.
    Vasilopoulos Y; Manolika M; Zafiriou E; Sarafidou T; Bagiatis V; Krüger-Krasagaki S; Tosca A; Patsatsi A; Sotiriadis D; Mamuris Z; Roussaki-Schulze A
    Mol Diagn Ther; 2012 Feb; 16(1):29-34. PubMed ID: 22111980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder.
    Talarowska M; Gałecki P; Maes M; Bobińska K; Kowalczyk E
    Neurochem Res; 2012 Aug; 37(8):1761-7. PubMed ID: 22562440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.